Literature DB >> 29317609

Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.

Mark James Rawle1, Daniel Davis2, Rebecca Bendayan2, Andrew Wong2, Diana Kuh2, Marcus Richards2.   

Abstract

We tested the association between APOE-ε4 and processing speed and memory between ages 43 and 69 in a population-based birth cohort. Analyses of processing speed (using a timed letter search task) and episodic memory (a 15-item word learning test) were conducted at ages 43, 53, 60-64 and 69 years using linear and multivariable regression, adjusting for gender and childhood cognition. Linear mixed models, with random intercepts and slopes, were conducted to test the association between APOE and the rate of decline in these cognitive scores from age 43 to 69. Model fit was assessed with the Bayesian Information Criterion. A cross-sectional association between APOE-ε4 and memory scores was detected at age 69 for both heterozygotes and homozygotes (β = -0.68 and β = -1.38, respectively, p = 0.03) with stronger associations in homozygotes; no associations were observed before this age. Homozygous carriers of APOE-ε4 had a faster rate of decline in memory between ages 43 and 69, when compared to non-carriers, after adjusting for gender and childhood cognition (β = -0.05, p = 0.04). There were no cross-sectional or longitudinal associations between APOE-ε4 and processing speed. We conclude that APOE-ε4 is associated with a subtly faster rate of memory decline from midlife to early old age; this may be due to effects of APOE-ε4 becoming manifest around the latter stage of life. Continuing follow-up will determine what proportion of this increase will become clinically significant.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29317609      PMCID: PMC5802532          DOI: 10.1038/s41398-017-0064-8

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  35 in total

1.  APOE polymorphism affects episodic memory among non demented elderly subjects.

Authors:  Simona De Blasi; Alberto Montesanto; Cinzia Martino; Serena Dato; Francesco De Rango; Amalia C Bruni; Vincenzo Mari; Emidio Feraco; Giuseppe Passarino
Journal:  Exp Gerontol       Date:  2008-11-24       Impact factor: 4.032

2.  Tau PET in Alzheimer disease and mild cognitive impairment.

Authors:  Hanna Cho; Jae Yong Choi; Mi Song Hwang; Jae Hoon Lee; You Jin Kim; Hye Mi Lee; Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

3.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

4.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

5.  Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Authors:  Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

6.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

7.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

Authors:  T Polvikoski; R Sulkava; M Haltia; K Kainulainen; A Vuorio; A Verkkoniemi; L Niinistö; P Halonen; K Kontula
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

8.  MUC7 haplotype analysis: results from a longitudinal birth cohort support protective effect of the MUC7*5 allele on respiratory function.

Authors:  K Rousseau; L E Vinall; S L Butterworth; R J Hardy; J Holloway; M E J Wadsworth; D M Swallow
Journal:  Ann Hum Genet       Date:  2006-07       Impact factor: 1.670

9.  Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development).

Authors:  Michael Wadsworth; Diana Kuh; Marcus Richards; Rebecca Hardy
Journal:  Int J Epidemiol       Date:  2005-10-04       Impact factor: 7.196

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  33 in total

1.  Apolipoprotein ɛ4 Allele and Subjective Cognitive Functioning in Parents of Adults With Disabilities.

Authors:  Jieun Song; Marsha R Mailick; Jan S Greenberg
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-09-14       Impact factor: 4.077

2.  Phenome-wide screening for traits causally associated with the risk of coronary artery disease.

Authors:  Majid Nikpay; Sara Mohammadzadeh
Journal:  J Hum Genet       Date:  2020-01-07       Impact factor: 3.172

3.  Dissociable effects of APOE-ε4 and β-amyloid pathology on visual working memory.

Authors:  Kirsty Lu; Jennifer M Nicholas; Yoni Pertzov; John Grogan; Masud Husain; Ivanna M Pavisic; Sarah-Naomi James; Thomas D Parker; Christopher A Lane; Ashvini Keshavan; Sarah E Keuss; Sarah M Buchanan; Heidi Murray-Smith; David M Cash; Ian B Malone; Carole H Sudre; William Coath; Andrew Wong; Susie M D Henley; Nick C Fox; Marcus Richards; Jonathan M Schott; Sebastian J Crutch
Journal:  Nat Aging       Date:  2021-10-07

4.  Moderating Role of Cognitive Reserve Markers Between Childhood Cognition and Cognitive Aging: Evidence From the 1946 British Birth Cohort.

Authors:  Pamela Almeida-Meza; Marcus Richards; Dorina Cadar
Journal:  Neurology       Date:  2022-08-03       Impact factor: 11.800

5.  Investigating a Genetic Link Between Alzheimer's Disease and CADASIL-Related Cerebral Small Vessel Disease.

Authors:  Paul J Dunn; Rodney A Lea; Neven Maksemous; Robert A Smith; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

6.  Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.

Authors:  Mengtian Du; Stacy L Andersen; Nicole Schupf; Mary F Feitosa; Megan S Barker; Thomas T Perls; Paola Sebastiani
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Authors:  Ryan J Piers; Yulin Liu; Ting F A Ang; Qiushan Tao; Rhoda Au; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.

Authors:  Oliver Bracko; Jean C Cruz Hernández; Laibaik Park; Nozomi Nishimura; Chris B Schaffer
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

9.  Nut Consumption for Cognitive Performance: A Systematic Review.

Authors:  Lauren E Theodore; Nicole J Kellow; Emily A McNeil; Evangeline O Close; Eliza G Coad; Barbara R Cardoso
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

10.  APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline.

Authors:  Steve R Makkar; Darren M Lipnicki; John D Crawford; Nicole A Kochan; Erico Castro-Costa; Maria Fernanda Lima-Costa; Breno Satler Diniz; Carol Brayne; Blossom Stephan; Fiona Matthews; Juan J Llibre-Rodriguez; Jorge J Llibre-Guerra; Adolfo J Valhuerdi-Cepero; Richard B Lipton; Mindy J Katz; Cuiling Wang; Karen Ritchie; Sophie Carles; Isabelle Carriere; Nikolaos Scarmeas; Mary Yannakoulia; Mary Kosmidis; Linda Lam; Wai Chi Chan; Ada Fung; Antonio Guaita; Roberta Vaccaro; Annalisa Davin; Ki Woong Kim; Ji Won Han; Seung Wan Suh; Steffi G Riedel-Heller; Susanne Roehr; Alexander Pabst; Mary Ganguli; Tiffany F Hughes; Beth Snitz; Kaarin J Anstey; Nicolas Cherbuin; Simon Easteal; Mary N Haan; Allison E Aiello; Kristina Dang; Tze Pin Ng; Qi Gao; Ma Shwe Zin Nyunt; Henry Brodaty; Julian N Trollor; Yvonne Leung; Jessica W Lo; Perminder Sachdev
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-25       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.